Important note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
![]()
Reuters NewMedia - November 20, 2003
The Centers for Disease Control and Prevention said the syphilis rate rose 9 percent between 2001 and 2002, the second straight yearly increase following a decade-long decline. The rate rose nearly 5 percent in 2001.
Untreated syphilis can cause insanity and death, as well as help spread HIV, the virus that causes AIDS.
While health experts said declines among black Americans and women showed the success of targeted education and testing programs, they also said the data posed new challenges to attacking the dramatic increase in syphilis among gay and bisexual men.
Syphilis among men rose 27 percent, to 5,267 cases in 2002 from 4,134 a year earlier. The CDC estimated that more than 40 percent of all syphilis cases last year were among men who have sex with men.
"Given the complex challenges that gay and bisexual men face, we don't expect to see immediate results from our efforts," Ronald Valdiserri, deputy director of the CDC's National Center for HIV, STD and TB Prevention, said during a teleconference.
The CDC said previous research has shown that a large percentage of gay and bisexual men with syphilis also have HIV.
In New York City, for example, gay men who are HIV positive made up 61 percent of syphilis cases last year, up from 20 percent in 1999. In other cities, an average of about 50 percent of recent syphilis cases were among people with HIV, the agency said.
Valdiserri said relaxed attitudes about safe sex in the wake of effective HIV treatment and problems with substance abuse and depression could explain the acceleration of syphilis in gay men, which is also being seen in the United Kingdom and elsewhere in Europe.
He said the study pointed to the need for routine testing for STDs among gay and bisexual men, and a need to extend prevention programs to emerging venues where these men can meet new partners, including the Internet.
031120
RE031123
Copyright © 2003 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .